Karl Egerer - Concepedia

Author

Karl Egerer

Charité - Universitätsmedizin Berlin

Also Known As

Egerer, Karl, K EGERER, K Egerer, K R Egerer, K. Egerer, K. R. Egerer, KARL EGERER, Karl Egerer, Karl R. Egerer

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Humboldt-Universität zu Berlin German Rheumatism Research Centre Euroimmun Medizinische Labordiagnostika (Germany)Research Institute for Farm Animal Biology (FBN)

About

Karl Egerer is an author at Charité - Universitätsmedizin Berlin specializing in heart failure, medicine, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	563
2	Health Sciences	2	2	155
3	Applied Physiology	1	1	84
4	Diabetes	1	1	71
5	Endocrinology	1	1	71

Karl Egerer

Publications

Citations

H-Index

Page 1

	Year	Citations
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients Katharina Hanke, Claudia Brückner, Cornelia Dähnrich, Arthritis Research & Therapy	2009	447
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure Stefan D. Anker, Karl Egerer, Hans‐Dieter Volk, The American Journal of Cardiology InflammationCardiomyopathyHeart FailureChronic Heart FailureCardiovascular Disease	1997	393
Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis Holger Bang, Karl Egerer, Anke Gauliard, Arthritis & Rheumatism	2007	291
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study J. Detert, H. Bastian, Joachim Listing, Annals of the Rheumatic Diseases	2012	186
Hyperprocalcitonemia in Patients with Noninfectious SIRS and Pulmonary Dysfunction Associated with Cardiopulmonary Bypass Mario Hensel, Thomas Volk, W D Döcke, Anesthesiology	1998	126
Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma Christian Jakob, Karl Egerer, Peter Liebisch, Blood	2006	125
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. Karl Egerer, Ulrike Kuckelkorn, Paul Rudolph, PubMed	2002	123
Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests Karl Egerer, Dirk Roggenbuck, Rico Hiemann, Arthritis Research & Therapy	2010	112
Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus Karl Egerer, E Feist, Ute Rohr, Lupus	2000	111
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia Wolfram Doehner, C.D. Pflaum, Mathias Rauchhaus, European Journal of Endocrinology	2001	105

Page 1